US Patent Litigations are now available. Check here

IP Verse

Tron Translationale Onkologie An Der Universittsmedizin Der Johannes Gutenberg Universitt Mainz Gemeinntzige patent opposition analysis

Latest patents of Tron Translationale Onkologie An Der Universittsmedizin Der Johannes Gutenberg Universitt Mainz Gemeinntzige opposed by its competitors

Explore Tron Translationale Onkologie An Der Universittsmedizin Der Johannes Gutenberg Universitt Mainz Gemeinntzige's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jun 12, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3791896Jan 10, 2024Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer3
EP3294325Jul 26, 2023Enhancing The Effect Of Car-Engineered T Cells By Means Of Nucleic Acid Vaccination1
EP3892295Apr 26, 2023Individualized Vaccines For Cancer1
EP3725810Jul 6, 2022Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer2
EP3126381Feb 16, 2022Claudin-6-Specific Immunoreceptors And T Cell Epitopes1
EP3473267Sep 8, 2021Individualized Vaccines For Cancer1
EP3254695Sep 9, 2020Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer1
EP3294333Sep 2, 2020Claudin-18.2-Specific Immunoreceptors And T Cell Epitopes1
EP2714071Jul 10, 2019Individualized Vaccines For Cancer3